+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Diagnostics Artificial Intelligence"

Artificial Intelligence (AI) in Clinical Trials Market - Product Thumbnail Image

Artificial Intelligence (AI) in Clinical Trials Market

  • Report
  • October 2025
  • 153 Pages
  • Global
From
From
From
From
Oncology Diagnostics: Global Markets - Product Thumbnail Image

Oncology Diagnostics: Global Markets

  • Report
  • May 2025
  • 192 Pages
  • Global
From
From
AI in Oncology for Analytical Solution Market 2025-2029 - Product Thumbnail Image

AI in Oncology for Analytical Solution Market 2025-2029

  • Report
  • August 2025
  • 251 Pages
  • Global
From
AI in Cancer Diagnostics Market 2025-2029 - Product Thumbnail Image

AI in Cancer Diagnostics Market 2025-2029

  • Report
  • August 2025
  • 243 Pages
  • Global
From
Cancer Early Detection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cancer Early Detection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
From
From
From
Oncology Market in India 2026-2030 - Product Thumbnail Image

Oncology Market in India 2026-2030

  • Report
  • January 2026
  • 195 Pages
  • India
From
From
Loading Indicator

The Cancer Diagnostics Artificial Intelligence market is a subset of the Artificial Intelligence industry that focuses on the development of AI-based solutions for the diagnosis and treatment of cancer. AI-based solutions are used to analyze medical images, such as CT scans and MRI scans, to detect cancerous cells and tumors. AI-based solutions can also be used to analyze patient data to identify patterns and predict outcomes. AI-based solutions are also used to develop personalized treatments for cancer patients. Companies in the Cancer Diagnostics Artificial Intelligence market include IBM Watson Health, Enlitic, Zebra Medical Vision, and Oncora Medical. Show Less Read more